Cognition Assessment and REhabilitation in Virtual Reality for Patients With Cancer
Starting soon · Not applicable
Conditions studied: Patients With Cancer
In brief
1. To assess the cognitive function of patients with cancer by leveraging a validated virtual reality (VR)-based cognitive assessment tool. 2. To evaluate the efficacy of VR-based cognitive rehabilitation therapy (VR-CRT) compared to a control group in improving cognitive functions in cancer patients. Hypothesis Cancer patients with cancer-related cognitive impairment who receive the VR-CRT program will demonstrate significantly greater improvement in cognitive functions, as measured by the validated VR cognition assessment tool, compared to those who receive standard care, both immediately post-intervention and at 3-month follow-up.
Key facts
- Study ID
- NCT07335393
- Run by
- JING MINGXUE
- People needed
- 64
- Starts
- 2026-01-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-01-13
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- (1) Cancer (both Solid and haematological) patients with documented cognitive impairments. (2) No history of neurological disorders. (3) Ability to use VR technology.
You may not qualify if…
- Severe visual or auditory impairments, motion sickness, or conditions interfering with VR use.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.